Badoud F, Perreault M, Zulyniak MA, Mutch DM Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 2015 Mar;29(3):748-58. doi: 10.1096/fj.14-263913. Epub 2014 Nov 19. Review.
Bradley D, Magkos F, Klein S Effects of bariatric surgery on glucose homeostasis and type 2 diabetes. Gastroenterology. 2012 Oct;143(4):897-912. doi: 10.1053/j.gastro.2012.07.114. Epub 2012 Aug 8. Review.
Dvorak RV, DeNino WF, Ades PA, Poehlman ET Phenotypic characteristics associated with insulin resistance in metabolically obese but normal-weight young women. Diabetes. 1999 Nov;48(11):2210-4.
Fontana L, Klein S, Holloszy JO Effects of long-term calorie restriction and endurance exercise on glucose tolerance, insulin action, and adipokine production. Age (Dordr). 2010 Mar;32(1):97-108. doi: 10.1007/s11357-009-9118-z. Epub 2009 Nov 11.
Geetha L, Deepa M, Anjana RM, Mohan V Prevalence and clinical profile of metabolic obesity and phenotypic obesity in Asian Indians. J Diabetes Sci Technol. 2011 Mar 1;5(2):439-46.
Goldstein DJ Beneficial health effects of modest weight loss. Int J Obes Relat Metab Disord. 1992 Jun;16(6):397-415. Review.
Jung CH, Lee MJ, Kang YM, Jang JE, Leem J, Hwang JY, Kim EH, Park JY, Kim HK, Lee WJ The risk of incident type 2 diabetes in a Korean metabolically healthy obese population: the role of systemic inflammation. J Clin Endocrinol Metab. 2015 Mar;100(3):934-41. doi: 10.1210/jc.2014-3885. Epub 2014 Dec 9. Erratum in: J Clin Endocrinol Metab. 2015 Apr;100(4):1709.
Kahn CR Insulin resistance, insulin insensitivity, and insulin unresponsiveness: a necessary distinction. Metabolism. 1978 Dec;27(12 Suppl 2):1893-902.
Kirk E, Reeds DN, Finck BN, Mayurranjan SM, Patterson BW, Klein S Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction. Gastroenterology. 2009 May;136(5):1552-60. doi: 10.1053/j.gastro.2009.01.048. Epub 2009 Jan 25. Erratum in: Gastroenterology. 2009 Jul;137(1):393. Mayurranjan, Mitra S [corrected to Mayurranjan S Mitra].
Klein S, Wadden T, Sugerman HJ AGA technical review on obesity. Gastroenterology. 2002 Sep;123(3):882-932. Review. Erratum in: Gastroenterology 2002 Nov;123(5):1752.
Lee K Metabolically obese but normal weight (MONW) and metabolically healthy but obese (MHO) phenotypes in Koreans: characteristics and health behaviors. Asia Pac J Clin Nutr. 2009;18(2):280-4.
Liew CF, Seah ES, Yeo KP, Lee KO, Wise SD Lean, nondiabetic Asian Indians have decreased insulin sensitivity and insulin clearance, and raised leptin compared to Caucasians and Chinese subjects. Int J Obes Relat Metab Disord. 2003 Jul;27(7):784-9.
Luo D, Liu F, Li X, Yin D, Lin Z, Liu H, Hou X, Wang C, Jia W Comparison of the effect of 'metabolically healthy but obese' and 'metabolically abnormal but not obese' phenotypes on development of diabetes and cardiovascular disease in Chinese. Endocrine. 2015 May;49(1):130-8. doi: 10.1007/s12020-014-0444-2. Epub 2014 Oct 14.
Ma S, Cutter J, Tan CE, Chew SK, Tai ES Associations of diabetes mellitus and ethnicity with mortality in a multiethnic Asian population: data from the 1992 Singapore National Health Survey. Am J Epidemiol. 2003 Sep 15;158(6):543-52.
Petersen KF, Dufour S, Morino K, Yoo PS, Cline GW, Shulman GI Reversal of muscle insulin resistance by weight reduction in young, lean, insulin-resistant offspring of parents with type 2 diabetes. Proc Natl Acad Sci U S A. 2012 May 22;109(21):8236-40. doi: 10.1073/pnas.1205675109. Epub 2012 Apr 30.
Tai ES, Lim SC, Chew SK, Tan BY, Tan CE Homeostasis model assessment in a population with mixed ethnicity: the 1992 Singapore National Health Survey. Diabetes Res Clin Pract. 2000 Aug;49(2-3):159-68.
Teixeira TF, Alves RD, Moreira AP, Peluzio Mdo C Main characteristics of metabolically obese normal weight and metabolically healthy obese phenotypes. Nutr Rev. 2015 Mar;73(3):175-90. doi: 10.1093/nutrit/nuu007. Epub 2015 Feb 13.
Yoo HJ, Hwang SY, Hong HC, Choi HY, Seo JA, Kim SG, Kim NH, Choi DS, Baik SH, Choi KM Association of metabolically abnormal but normal weight (MANW) and metabolically healthy but obese (MHO) individuals with arterial stiffness and carotid atherosclerosis. Atherosclerosis. 2014 May;234(1):218-23. doi: 10.1016/j.atherosclerosis.2014.02.033. Epub 2014 Mar 16.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.